Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 9 - Drugs for disorders of the cardiovascular system
Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484)
05/2003
05/21/2003CN1419548A 4-amino-5-cyano-2-anilino-pyrimidine derivatives and their use as inhbitors of cell-cycle kinases
05/21/2003CN1419546A 4,5-dihydro-1h-pyrazole derivatives having cbi-antagonistic activity
05/21/2003CN1419545A 3-cyanoquinolines, 3-cyano-1,6-naphthyridines, and 3-cyano-1,7-naphthyridines as protein kinase inhibitors
05/21/2003CN1419541A Pharmaceutically active pyrrolidine derivatives as BAX inhibitors
05/21/2003CN1419539A Amidino compound and salts thereof useful as nitric oxide synahase inhibitors
05/21/2003CN1419532A Novel fatty acid analogous
05/21/2003CN1419453A Pharmaceutical gel composition
05/21/2003CN1419451A Novel galneical form for oral administration with prolonged release of molsidomine
05/21/2003CN1419448A Remedies
05/21/2003CN1419445A Agent and binding agent for pharmaceutical formulations with improved storage stability
05/21/2003CN1419124A Method for controlling quality of compound red sage root preparation used for treating cardio-cerebral vascualr disease
05/21/2003CN1418882A Substituted sulfonic N-[(amino imino methyl) phenyl alkyl]-acacycloamide compound
05/21/2003CN1418869A 2-propyl valeramide and 2-propyl pentaenuylamide derivative and application used as anti-convulsion medicine
05/21/2003CN1418695A Traditional Chinese medicine for treating perineum disease
05/21/2003CN1418690A Erigreron Breviscapus compound preparation and medical use thereof
05/21/2003CN1418678A Medicine compositions for treating cardiovascular cranialvascular disease, and its prepn. method
05/21/2003CN1418653A Xin-nao-ning capsule for treating cardio-vascular and cerebral vascular disease
05/21/2003CN1418646A Traditional Chinese medicine for treating CAHD
05/21/2003CN1418645A Traditional Chinese medicine powder with functions of activating channels, relieving pain, dispelling wind-evil and strengthening-bone
05/21/2003CN1418644A Compound traditional Chinese medicine granule for treating CVD
05/21/2003CN1418627A Nitrophendipine oral disintegrant for treating angina pectoris, and its prepn. method
05/21/2003CN1418626A Nimodipine lipid nano particle compositions, and its prepn. method
05/21/2003CN1418623A Prepn. of obakulactone contd. medicine for treating hemorrhoid, and its use
05/21/2003CN1418621A WEILAPAMI oral disintegrant for treating irrhythmia, and its prepn. method
05/21/2003CN1109047C Amphiapathic moleculs as cholesterol and other lipid uptake inhibitors
05/21/2003CN1108967C Metering valve
05/21/2003CN1108812C Helath care tea and preparation method thereof
05/21/2003CN1108811C Monglian medicine for curing ischemic heart disease
05/21/2003CN1108803C Medicine for treating piles and its preparing process
05/21/2003CN1108798C Compound preparation for curing and preventing thrombosis and apoplexy and its preparing method
05/21/2003CN1108797C Quinazolinone pharmaceuticals and use thereof
05/20/2003WO2003044037A2 Process for the manufacture of human mononuclear phagocytic leukocytes
05/20/2003US6566554 Including amino benzothiophenones; useful for treatment of inflammatory diseases in which the production of cytokines is involved in the pathogenesis
05/20/2003US6566543 2-arachidonylglycerol (2-AG)-an inhibitor of tumor necrosis factor-α and neuroprotector of brain in closed head injury
05/20/2003US6566542 Such as 17-alpha-fluoro-11-beta-(4-(2-(1-piperidinyl) ethoxy) phenyl)-estra-1,3,5(10)-trien-3-ol for treatment of osteoporosis and cardiovascular protection; side effect reduction; provides alternative to estradiol
05/20/2003US6566538 Substituted oxygen alicyclic compounds, including methods for synthesis thereof
05/20/2003US6566506 Useful in extending the in vivo circulating life of biologically active materials
05/20/2003US6566491 Cyclopeptide derivatives
05/20/2003US6566398 Method for treatment of external secretion disorders
05/20/2003US6566387 For therapy of psoriasis, atopic dermatitis, arthritis, asthma, chronic obstructive pulmonary disease, adult respiratory distress syndrome, inflammatory bowel disease, Crohn's disease, ulcerative colitis, stroke, septic shock
05/20/2003US6566380 For therapy of cardiac arrhythmias
05/20/2003US6566379 Heteroaryl aminoguanidines and alkoxyguanidines and their use as protease inhibitors
05/20/2003US6566377 Have utility as, inter alia, hypoglycemic, and anti-obesity agents.
05/20/2003US6566368 Aministering apomorphine or a pharmaceutically acceptable acid addition salt thereof intranasally and in an amount sufficient to induce an erection adequate for vaginal penetration but less than the amount that induces substantial nausea
05/20/2003US6566367 Spiro[isobenzofuran-1,4′-piperidin]-3-ones and 3H-spiroisobenzofuran-1,4′-piperidines
05/20/2003US6566366 Thienyl substituted acylguanidines as inhibitors of bone resorption and vitronectin receptor antagonists
05/20/2003US6566364 Linear or cyclic ureas
05/20/2003US6566363 5-amino-3-substituted-pyrazolo(4,5-d)thiazole compounds that mediate and/or inhibit the activity of cyclin-dependent kinases, useful for treating cancer, angiogenesis and cellular proliferation
05/20/2003US6566360 2-phenyl substituted imidatriazinones as phosphodiesterase inhibitors
05/20/2003US6566357 Spirocyclic-6,7-dihydro-5H-pyrazolo[1,2-a]pyrazol-1-ones which control inflammatory cytokines
05/20/2003US6566340 Aryl-substituted propanolamine derivatives, their preparation, pharmaceuticals comprising them, and their use
05/20/2003US6566325 And isolated nucleic acids containing coding regions of genes encoding such proteins; for use in gene therapy treatment of cancer, autoimmune diseases, viral diseases
05/20/2003US6566065 Diagnosing schizophrenia in humans; obtain sample, analyze the methylenetetrahydrofolate reductase nucleic acid expression in sample, genotype sample, presence of mutation indicates schizophrenia
05/20/2003US6565876 Carnitine and inositol phosphate-containing composition useful as dietary supplement or drug
05/20/2003US6565851 Relieving symptoms of erectile dysfunction with proanthocyanidins
05/20/2003US6565850 Hemorrhoidal compositions and method of use
05/20/2003CA2322944C Functionalized alkyl and alkenyl side chain derivatives of glycinamides as farnesyl transferase inhibitors
05/20/2003CA2223016C Protein tyrosine kinase aryl and heteroaryl quinazoline compounds having selective inhibition of her-2 autophosphorylation properties
05/20/2003CA2088254C Treatment for hypercholesterolemia
05/15/2003WO2003040691A2 Soluble cd40l(cd154) as a prognostic marker of atherosclerotic diseases
05/15/2003WO2003040399A2 Therapeutic methods for nucleic acid delivery vehicles
05/15/2003WO2003040375A1 COMPOSITIONS AND PROCESSES USING siRNA, AMPHIPATHIC COMPOUNDS AND POLYCATIONS
05/15/2003WO2003040371A1 Novel g protein-coupled receptor protein and dna thereof
05/15/2003WO2003040366A2 Inhibitor oligonucleotides and their use for specific repression of a gene
05/15/2003WO2003040358A1 Somatic cell derived embryonic stem cells and its differentiated cells
05/15/2003WO2003040329A2 Therapeutic polypeptides, nucleic acids encoding same, and methods of use
05/15/2003WO2003040296A2 Men protein, gst2, rab-rp1, csp, f-box protein lilina/fbl7, abc50, coronin, sec61 alpha, or vhappa1-1, or homologous proteins involved in the regulation of energy homeostasis
05/15/2003WO2003040188A1 Antibody stimulating il-1ra production
05/15/2003WO2003040174A2 Substituted amino ketone compounds
05/15/2003WO2003040144A2 Heterocyclic compound based on n6-substituted adenine, methods of their preparation, their use for preparation of drugs, cosmetic preparations and growth regulators, pharmaceutical preparations, cosmetic preparations and growth regulators containing these compounds
05/15/2003WO2003040143A1 Amine salts of an integrin receptor antagonist
05/15/2003WO2003040134A1 Methods for preparing an estrogenic preparation and isolated estrogenic compounds from a plant and uses thereof
05/15/2003WO2003040122A1 Novel mandelate salts of substituted tetracyclic tetrahydrofuran derivatives
05/15/2003WO2003040121A1 Methods for treating depression and other cns disorders using enantiomerically enriched desmethyl- and didesmethyl-metabolites of citalopram
05/15/2003WO2003040119A1 Angiogenesis inhibitors
05/15/2003WO2003040115A1 2-amino-thiazoline derivatives and their use as inhibitors of inducible no-synthase
05/15/2003WO2003040108A1 Quinazoline derivatives as antitumor agents
05/15/2003WO2003040107A1 Imidazole-4-carboxamide derivatives, preparation and use thereof for treatment of obesity
05/15/2003WO2003040106A1 Preparation and use of substituted imidazoles
05/15/2003WO2003040102A1 Anthranilic acid amides and their use as vegf receptor tyrosine kinase inhibitors
05/15/2003WO2003040101A1 Anthranilic acid amides and pharmaceutical use thereof
05/15/2003WO2003040099A1 Preparation of benzosuberonylpiperidine compounds
05/15/2003WO2003040098A1 Novel metalloproteinase inhibitors
05/15/2003WO2003040097A1 Nitrogenous compounds, production process, and method of use thereof
05/15/2003WO2003040086A1 5-amidino-2-hydroxybenzenesulfonamide derivatives, medicinal compositions containing the same, medicinal use thereof and intermediates in the production thereof
05/15/2003WO2003040084A1 Unsaturated 1-amino-alkylcyclohexane nmda, 5ht3 and neuronal nicotinic receptor antagonists
05/15/2003WO2003040080A2 Lipoxin a4 analogs
05/15/2003WO2003039616A1 Percutaneous transluminal drug delivery device
05/15/2003WO2003039590A1 Pharmaceutical composition comprising factor vii polypeptides and aprotinin polypeptides
05/15/2003WO2003039584A1 Pharmaceutical composition comprising factor vii polypeptides and factor v polypeptides
05/15/2003WO2003039580A1 Pharmaceutical composition comprising factor vii polypeptides and pai-1 polypeptides
05/15/2003WO2003039578A1 Treatment of congestive heart failure
05/15/2003WO2003039574A1 Endophilin homologous proteins involved in the regulation of energy homeostasis
05/15/2003WO2003039569A1 Process for the preparation of anthocyanin-containaing products
05/15/2003WO2003039564A1 Selective targeting of apoptotic cells
05/15/2003WO2003039553A1 Compositions for treatment of postmenopausal female sexual dysfunction
05/15/2003WO2003039551A1 Combination therapy comprising zd6474 and a taxane
05/15/2003WO2003039548A1 Hydrazono-malonitriles
05/15/2003WO2003039544A1 Naphtyridine derivatives, their preparation and their use as phosphodiesterase isoenzyme 4 (pde4) inhibitors
05/15/2003WO2003039543A1 Derivatives of phenoxy-n-'4-(isothiazolidin-1,1-dioxid-2yl)pheny!-valerian- acid amide and other compounds as inhibitors of the coagulation factor xa in the treatment of thromboembolic diseases and tumors
1 ... 1010 1011 1012 1013 1014 1015 1016 1017 1018 1019 1020 1021 1022 1023 1024 1025 1026 1027 1028 1029 1030 ... 1595